<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Zakharova E</submitter><funding>Swiss National Science Foundation</funding><funding>European Research Council</funding><pagination>e202200291</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9541320</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>17(17)</volume><pubmed_abstract>Most antimicrobial peptides (AMPs) and anticancer peptides (ACPs) fold into membrane disruptive cationic amphiphilic α-helices, many of which are however also unpredictably hemolytic and toxic. Here we exploited the ability of recurrent neural networks (RNN) to distinguish active from inactive and non-hemolytic from hemolytic AMPs and ACPs to discover new non-hemolytic ACPs. Our discovery pipeline involved: 1) sequence generation using either a generative RNN or a genetic algorithm, 2) RNN classification for activity and hemolysis, 3) selection for sequence novelty, helicity and amphiphilicity, and 4) synthesis and testing. Experimental evaluation of thirty-three peptides resulted in eleven active ACPs, four of which were non-hemolytic, with properties resembling those of the natural ACP lasioglossin III. These experiments show the first example of direct machine learning guided discovery of non-hemolytic ACPs.</pubmed_abstract><journal>ChemMedChem</journal><pubmed_title>Machine Learning Guided Discovery of Non-Hemolytic Membrane Disruptive Anticancer Peptides.</pubmed_title><pmcid>PMC9541320</pmcid><funding_grant_id>200020</funding_grant_id><funding_grant_id>885076</funding_grant_id><funding_grant_id>200020_178998</funding_grant_id><funding_grant_id>178998</funding_grant_id><funding_grant_id>407240_167048</funding_grant_id><pubmed_authors>Reymond JL</pubmed_authors><pubmed_authors>Capecchi A</pubmed_authors><pubmed_authors>Zakharova E</pubmed_authors><pubmed_authors>Orsi M</pubmed_authors></additional><is_claimable>false</is_claimable><name>Machine Learning Guided Discovery of Non-Hemolytic Membrane Disruptive Anticancer Peptides.</name><description>Most antimicrobial peptides (AMPs) and anticancer peptides (ACPs) fold into membrane disruptive cationic amphiphilic α-helices, many of which are however also unpredictably hemolytic and toxic. Here we exploited the ability of recurrent neural networks (RNN) to distinguish active from inactive and non-hemolytic from hemolytic AMPs and ACPs to discover new non-hemolytic ACPs. Our discovery pipeline involved: 1) sequence generation using either a generative RNN or a genetic algorithm, 2) RNN classification for activity and hemolysis, 3) selection for sequence novelty, helicity and amphiphilicity, and 4) synthesis and testing. Experimental evaluation of thirty-three peptides resulted in eleven active ACPs, four of which were non-hemolytic, with properties resembling those of the natural ACP lasioglossin III. These experiments show the first example of direct machine learning guided discovery of non-hemolytic ACPs.</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Sep</publication><modification>2025-04-19T04:49:44.849Z</modification><creation>2025-04-19T04:49:44.849Z</creation></dates><accession>S-EPMC9541320</accession><cross_references><pubmed>35880810</pubmed><doi>10.1002/cmdc.202200291</doi></cross_references></HashMap>